Researchers have used a cutting-edge robotic system capable of synthesizing hundreds of metal complexes to develop a possible ...

The revised EU pharmaceutical policy maintains eight-year data protection but reduces market protection to one year, ...

Ultimately, these advancements suggest a more integrated ecosystem. Trusted regulatory spaces function like a communal ...

Invivyd, Inc. (Nasdaq: IVVD) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for VYD2311, an investigational vaccine-alternative monoclonal antibody ...

A push to reshore some drug production and progress in advanced manufacturing technologies have been prominent trends this year, industry leaders say.

Q4 2025 Earnings Call Transcript December 17, 2025 Operator: Good day, ladies and gentlemen. Welcome to the Fourth Quarter of Fiscal Year 2025 Financial Results Conference Call for NeuroOne Medical ...

DehydraTECH-semaglutide reduced overall side effects by 48% as compared to Rybelsus® DehydraTECH-semaglutide reduced gastrointestinal side effects by 55% as compared to Rybelsus® Recent financings ...

The blood-brain barrier (BBB) is the body’s most vital line of defense and, at the same time, is also one of modern ...

Embryos and the uterus exchange molecular signals within the first hour, shaping whether implantation succeeds or fails.

The U.S. Food and Drug Administration has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and ...